Incidence and clinical complications of vancomycin-resistant enterococcus in pediatric stem cell transplant patients

Bone Marrow Transplantation

Volumn 33, Issue 9, 2004, Pages 937-941

  Tsiatis, A C ^a   Manes, B ^a   Calder, C ^a   Billheimer, D ^b   Wilkerson, K S ^b   Frangoul, Haydar ^a,c  

^a MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Infection control; Pediatric stem cell transplantation; Vancomycin resistant enterococcus

Indexed keywords

AMPICILLIN; CEPHALOSPORIN; DALFOPRISTIN PLUS QUINUPRISTIN; GENTAMICIN; LINEZOLID; RAMOPLANIN; STREPTOMYCIN; VANCOMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BACTERIUM DETECTION; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; ENTEROCOCCUS; FEMALE; GRAM NEGATIVE SEPSIS; HEMATOLOGIC DISEASE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PATIENT CARE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HEMATOLOGIC NEOPLASMS; HUMANS; INFANT; INFECTION CONTROL; MALE; NEOPLASMS; STEM CELL TRANSPLANTATION; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 2442688027     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704462     Document Type: Article

References (23)

1. LeClercq R, Derlot E, Duval J et al. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988; 319: 157-161.
2. Uttley AH, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet 1988; 1: 57-58.
3. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. Morb Mortal Wkly Rep 1993; 42: 597-599.
4. Bakir M, Bova JL, Newell KA et al. Epidemiology and clinical consequences of vancomycin resistant enterococci in liver transplant patients. Transplantation 2001; 72: 1032-1037.
5. Orloff SL, Busch AMH, Olyaei AJ et al. Vancomycin-resistant enterococcus in liver transplant patients. Am J Surg 1999; 177: 418-422.
6. Patel R, Allen SL, Manahan JM et al. Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipients. Liver Transplant 2001; 7: 27-31.
7. Newell KA, Millis JM, Arnow PM et al. Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation. Transplantation 1998; 65: 439-442.
8. Pfundstein J, Roghmann MC, Schwalbe RS et al. A randomized trial of surgical antimicrobial prophylaxis with and without vancomycin in organ transplant patients. Clin Transplant 1999; 13: 245-252.
9. Peetermans WE, Sebens FW, Guiot FL. Vancomycin-resistant Enterococcus faecalis in a bone-marrow transplant recipient. Scand J Infect Dis 1991; 23: 105-109.
10. Kapur D, Dorsky D, Feingold JM et al. Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2000; 25: 147-152.
11. Koc Y, Snydman DR, Schenkein DS, Miller KB. Case report: vancomycin-resistant enterococcal infections in bone marrow transplant recipients. Bone Marrow Transplant 1998; 22: 207-209.
12. Edmond MB, Ober JF, Dawson JD et al. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 1996; 23: 1234-1239.
13. Shay KD, Maloney SA, Montecalvo MJ. Epidemiology and mortality risk of vancomycin-resistant enterococcal blood-stream infections. J Infect Dis 1995; 172: 993-1000.
14. Noskin GA, Cooper I, Peterson LR. Vancomycin-resistant Enterococcus faecium sepsis following persistent colonization. Arch Intern Med 1995; 155: 1445-1447.
15. Carretto E, Barbarini D, Locatelli F et al. Vancomycin-resistant Enterococcus faecium infection in three children given allogeneic hematopoietic stem cell transplantation: clinical and microbiological features. Haematologica 2000; 85: 1158-1164.
16. Gregory JJ, Small TN, Papadopoulos E et al. Influence of vancomycin-resistant enterococcus on the outcome of recipients of bone marrow transplants. Proc Am Soc Clin Oncol 1999; 18: 51a (abstract).
17. Schuster F, Graubner UB, Schmid I et al. Vancomycin-resistant enterococci - colonization of 24 patients on a pediatric oncology unit. Klin Pediatr 1998; 210: 261-263.
18. Singh-Naz N, Sleemi A, Pikis A et al. Vancomycin-resistant Enterococcus faecium colonization in children. J Clin Microbiol 1999; 37: 413-416.
19. Nourse C, Murphy H, Byrne C et al. Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: risk factors for colonisation. Eur J Pediatr 1998; 157: 20-27.
20. Kirkpatrick BD, Harrington SM, Smith D et al. An outbreak of vancomycin-dependent Enterococcus faecium in a bone marrow transplant unit. Clin Infect Dis 1999; 29: 1268-1273.
21. Weinstein MR, Dedier H, Brunton J et al. Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium. Clin Infect Dis 1999; 29: 361-363.
22. Wong MT, Kauffman CA, Ramoplanin VRE2 Clinical Study Group et al. Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin. Clin Infect Dis 2001; 33: 1476-1482.
23. Hierholzer WJ, Garner JS, Adam AB. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Am J Infect Control 1995; 23: 87-94.